Humacyte (HUMA) Non-Current Assets (2020 - 2026)

Humacyte (HUMA) has 7 years of Non-Current Assets data on file, last reported at $47.0 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $47.0 million, down 47.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $232.8 million (down 25.59% YoY), and the FY2025 annual result was $48.6 million, down 46.04% from the prior year.
• Non-Current Assets eased to $47.0 million in Q1 2026 per HUMA's latest filing, from $48.6 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $91.8 million in Q3 2024 and troughed at $42.2 million in Q2 2024.
• A 5-year average of $58.1 million and a median of $50.1 million in 2022 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2025 and 2026: Non-Current Assets soared 106.46% in 2025, then tumbled 47.15% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $50.1 million in 2022, then retreated by 10.28% to $44.9 million in 2023, then soared by 100.27% to $90.0 million in 2024, then plunged by 46.04% to $48.6 million in 2025, then slipped by 3.32% to $47.0 million in 2026.
• Business Quant data shows HUMA's Non-Current Assets at $47.0 million in Q1 2026, $48.6 million in Q4 2025, and $50.2 million in Q3 2025.